Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia

NCT00451763 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT00451763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00451763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia
Lead sponsor
University of Sao Paulo
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
December 31, 2007
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retina, telangiectasis